Laurent Fischer, CEO, President and Director at Adverum Biotechnologies, Inc. (ADVM), bought 25,000 shares at $1.79 ($46K) on 2021-12-08, disclosed to the SEC on 2021-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.79 | 10,677 | $19K | 41.9% |
| 2 | $1.85 | 14,323 | $26K | 58.1% |
| Total | $1.82 avg | 25,000 | $46K | 100% |
| Filing → |
| ADVM | SELL | 2023-03-17 | $32K | — | Filing → |
| ADVM | SELL | 2022-09-21 | $44K | — | Filing → |
| ADVM | BUY | 2022-04-22 | $28K | — | Filing → |